Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
0.642 %
$ 428 M
Market Cap
-3.15
P/E
EYPT - GROSS PROFIT
Gross Profit EYPT - EyePoint Pharmaceuticals, Inc.
41.4 M
LAST VALUE
19.95%
2 YEAR CAGR
36.06%
5 YEAR CAGR
22.44%
10 YEAR CAGR